Boulding Mark Elliott sold PTCT
January 7, 2026 · Form 4 insider transaction
Boulding Mark Elliott sold 1,503 shares of PTC Therapeutics, Inc. at $77.48 per share, a transaction worth $116.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,503
Price
$77.48
Total value
$116.5K
InsiderBoulding Mark Elliott
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 7, 2026
Filing dateJanuary 8, 2026
Shares owned after117,659
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 4,250 RSUs from a January 5, 2023 grant of 17,000 RSUs.